Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The antidiuretic effect of arginine vasopressin (AVP) is mediated by renal-type (V2) receptors linked to adenylyl cyclase. We report here the cloning of the rat kidney V2 AVP receptor complementary DNA that encodes a 370-amino-acid protein with a transmembrane topography characteristic of G protein-coupled receptors, and with similarity to the V1a (hepatic) AVP receptor in its seven membrane-spanning domains. Expression of the cloned cDNA in mammalian cells showed specific ligand binding and activity characteristic of the native V2 AVP receptor. The receptor messenger RNA is detected only in the kidney. The human V2 receptor gene has been localized to the long arm of the X chromosome close to the locus for nephrogenic diabetes insipidus, an X-linked recessive disorder characterized by renal resistance to the antidiuretic action of AVP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,577
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Self-citationExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
Research works printed but not linked: 1
- Holmes, M. C., Antoni, F. A. & Szentendrei, T. Neuroendocrinology 117, 421–423 (1985).
Cited by
Items 201–300 of 523
Brain vasopressin is involved in stress-induced suppression of immune function in the rat
Shibasaki, T., Hotta, M., Sugihara, H., & Wakabayashi, I. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00843-9 · Cited by 36
Jeng, Y., Lolait, S. J., Straková, Z., Chen, C., Copland, J. A., Mellman, D. L., Hellmich, M. R., & Soloff, M. S. (1996) · Neuropeptides · doi:10.1016/s0143-4179(96)90039-6 · Cited by 36
Self-citationThibonnier, M., Coles, P., Conarty, D. M., Plesnicher, C. L., & Shoham, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39056-1 · Cited by 35
Enhanced effect of neuropeptide Y on food intake caused by blockade of the V1A vasopressin receptor
Aoyagi, T., Kusakawa, S., Sanbe, A., Hiroyama, M., Fujiwara, Y., Yamauchi, J., & Tanoue, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.017 · Cited by 38
Pathophysiology of renal fluid retention
Schrier, R. W., Fassett, R. G., Ohara, M., & Martin, P. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06724.x · Cited by 35
Singh, V. K., & Joy, K. P. (2011) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2011.07.009 · Cited by 35
Nicotine stimulates secretion of corticosterone via both CRH and AVP receptors
Lutfy, K., Aimiuwu, O., Mangubat, M., Shin, C., Nerio, N., Gomez, R., Liu, Y., & Friedman, T. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07633.x · Cited by 42
“Three subtypes of vasopressin receptors (V1a, V2 and V1b or V3) have been cloned (Lolait et al. 1992; Morel et al. 1992; de Keyzer et al. 1996).”
Funabashi, T., Shinohara, K., Mitsushima, D., & Kimura, F. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01069-7 · Cited by 37
Sproul, A. D., Steele, S. L., Thai, T. L., Yu, S.-P., Klein, J. D., Sands, J. M., & Bell, P. D. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00666.2010 · Cited by 35
Chen, C., Chen, W.-Y., Liu, H.-L., Liu, T., Tsou, A.-P., Lin, C.-Y., Chao, T., Qi, Y., & Hsiao, K. J. (2002) · Journal of Human Genetics · doi:10.1007/s100380200002 · Cited by 34
“The gene encodes a 371-amino acid G protein-coupled receptor that has seven transmembrane domains, four extracellular domains, and four cytoplasmic domains (Birnbaumer et al. 1992; Lolait et al. 1992; Rosenthal et al. 1992).”
BackgroundFernández, N., Garcı́a, J. L., Garcı́a-Villalón, Á. L., Monge, L., Gómez, B., & Diéguez, G. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01504-5 · Cited by 34
Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors
Morel, A., Lolait, S. J., & Brownstein, M. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90182-8 · Cited by 35
Self-citationMohr, E., Meyerhof, W., & Richter, D. (1995) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61040-7 · Cited by 38
HOWL, J., & WHEATLEY, M. (1996) · Biochemical Journal · doi:10.1042/bj3170577 · Cited by 34
Oksche, A., Leder, G., Valet, S., Platzer, M., Hasse, K., Geist, S., Krause, G., Rosenthal, A., & Rosenthal, W. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0796 · Cited by 34
Wortmannin inhibits the activation of MAP kinase following vasopressin V1 receptor stimulation
Nishioka, N., Hirai, S.-I., Mizuno, K., Osada, S., Suzuki, A., Kosaka, K., & Ohno, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01382-2 · Cited by 34
Neocleous, V., Skordis, N., Shammas, C., Efstathiou, E., Mastroyiannopoulos, N. P., & Phylactou, L. A. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.005 · Cited by 33
Cell Cycle-dependent Coupling of the Vasopressin V1a Receptor to Different G Proteins
Abel, A., Wittau, N., Wieland, T., Schultz, G., & Kalkbrenner, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002171200 · Cited by 33
Molecular evolution of the oxytocin–oxytocin receptor system in eutherians
Yamashita, K., & Kitano, T. (2013) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2013.02.017 · Cited by 33
Jia, X., Perlas, E., Su, J.-G. J., Moran, F. M., Lasley, B. L., Ny, T., & Hsueh, A. J. W. (1993) · Biology of Reproduction · doi:10.1095/biolreprod49.6.1310 · Cited by 33
“Furthermore, recent isolation of cDNAs for FSH and TSH receptors [28-30] as well as receptors for other hormones known to activate the cAMP pathway (VIP, AVP, and calcitonin [31-33]) also allows the establishment of specific bioassays for these hormones.”
BackgroundCroiset, G., & de Wied, D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00070-x · Cited by 33
Andrés, M., Trueba, M., & Guillon, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704634 · Cited by 34
“This pharmacological classi®cation was con®rmed later by the cloning of three distinct genes encoding for V2, V1a and V1b receptors (Lolait et al., 1992; Morel et al., 1992; Sugimoto et al., 1994).”
BackgroundSato, M., Ohguro, H., Ohguro, I., Mamiya, K., Takano, Y., Yamazaki, H., Metoki, T., Miyagawa, Y., Ishikawa, F., & Nakazawa, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01092-1 · Cited by 32
The Property of a Novel V2 Receptor Mutant in a Patient with Nephrogenic Diabetes Insipidus
Inaba, S., Hatakeyama, H., Taniguchi, N., & Miyamori, I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.381 · Cited by 32
Arginine Vasotocin: Site and Mode of Action in the Reptilian Kidney
Bradshaw, D., & Bradshaw, F. J. (2002) · General and Comparative Endocrinology · doi:10.1006/gcen.2002.7780 · Cited by 32
“The effects of AVP on water reabsorption in the mammalian kidney act through this V2 receptor coupled to a G-protein receptor stimulating cyclic AMP (cAMP) as a second messenger and leading to the permeabilization of the medullary collecting ducts through the insertion of aquaporin molecules in the basal membrane (Lol…”
BackgroundNakamura, S., Yamamura, Y., Itoh, S., Hirano, T., Tsujimae, K., Aoyama, M., Kondo, K., Ogawa, H., Shinohara, T., Kan, K., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703221 · Cited by 32
“Since molecular cloning of human AVP receptor subtypes was identi®ed (Birnbaumer et al., 1992; de Keyzer et al., 1994; Hirasawa et al., 1994; Lolait et al., 1992; Sugimoto et al., 1994; Thibonnier et al., 1994), we designed the stable expression of each human AVP receptor in HeLa cells (Yamamura et…”
MethodArginine Vasopressin Increases Nitric Oxide Synthesis in Cytokine-Stimulated Rat Cardiac Myocytes
Yamamoto, K., Ikeda, U., Okada, K., Saito, T., Kawahara, Y., Okuda, M., Yokoyama, M., & Shimada, K. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1112 · Cited by 32
Akhundova, A., Getmanova, E. V., Gorbulev, V., Carnazzi, E., Eggena, P., & Fahrenholz, F. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0759p.x · Cited by 35
Pathogenesis of Sodium and Water Retention in Cardiac Failure
Schrier, R. W., & Fassett, R. G. (1998) · Renal Failure · doi:10.3109/08860229809045175 · Cited by 32
Cheng, L. L., Stoev, S., Manning, M., Derick, S., Pena, A., Mimoun, M. B., & Guillon, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030611c · Cited by 32
Pharmacological Chaperones in Nephrogenic Diabetes Insipidus
Robben, J. H., & Deen, P. M. T. (2007) · BioDrugs · doi:10.2165/00063030-200721030-00003 · Cited by 31
Ishikawa, S. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050933 · Cited by 31
“G-protein-coupled receptors [13].”
Vasopressin-induction of cyclic AMP in cultured hippocampal neurons
Brinton, R. D., & Brownson, E. A. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90110-v · Cited by 34
Endocrine Control of Water Balance
Andreoli, T. E., Reeves, W. B., & Bichet, D. G. (2000) · Comprehensive physiology · doi:10.1002/cphy.cp070314 · Cited by 31
Roles of arginine vasotocin receptors in the brain and pituitary of submammalian vertebrates
(2013) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-407696-9.00004-x · Cited by 30
“The V2 receptor is located in the kidney, where it regulates water reabsorption (Lolait et al., 1992).”
BackgroundInfluentialArmstrong, S. P., Seeber, R. M., Ayoub, M. A., Feldman, B. J., & Pfleger, K. D. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065885 · Cited by 30
AVT is involved in the regulation of ion transport in the intestine of the sea bream (Sparus aurata)
Martos-Sitcha, J. A., Gregório, S. F., Carvalho, E., Canário, A. V. M., Power, D. M., Mancera, J. M., Martínez-Rodríguez, G., & Fuentes, J. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.07.017 · Cited by 34
Evidence for expression of vasopressin V2 receptor mRNA in human lung
Fay, M. J., Du, J., Yu, X., & North, W. G. (1996) · Peptides · doi:10.1016/0196-9781(96)00009-5 · Cited by 30
Evidence that atypical vasopressin V2 receptor in inner medulla of kidney is V1B receptor
Saito, M., Tahara, A., Sugimoto, T., Abe, K., & Furuichi, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00465-9 · Cited by 30
AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells
Yamada, T., Terada, Y., Homma, M. K., Nonoguchi, H., Sasaki, S., Yuasa, Y., Tomita, K., & Marumo, F. (1995) · Kidney International · doi:10.1038/ki.1995.346 · Cited by 30
Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction
Jensen, A. M., Bae, E. H., Fenton, R. A., Nørregaard, R., Nielsen, S. S., Kim, S. W., & Frøkiær, J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90479.2008 · Cited by 29
Wu, C., Lv, C., Wan, Y., Li, X., Zhang, J., Li, J., & Wang, Y. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.05.013 · Cited by 31
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study
RenalTube Group, García‐Castaño, A., de Nanclares, G. P., Madariaga, L., Aguirre, M., Chocrón, S., Madrid, Á., Tejedor, F. J. L., Gil‐Campos, M., del Pozo, J. S., et al. (2015) · European Journal of Pediatrics · doi:10.1007/s00431-015-2534-4 · Cited by 29
“Upon removal of ADH, AQP-2 is retrieved by endocytosis [25, 27, 35, 38] Eur J Pediatr (2015) 174:1373–1385 1375”
Photoreceptor processing improves salience facilitating small target detection in cluttered scenes
Brinkworth, R. S. A., Mah, E.-L., Gray, J., & O’Carroll, D. C. (2008) · Journal of Vision · doi:10.1167/8.11.8 · Cited by 29
Molecular Endocrinology of the Oxytocin Receptor.
Kimura, T., & Saji, F. (1995) · Endocrine Journal · doi:10.1507/endocrj.42.607 · Cited by 30
Yazawa, H., Hirasawa, A., Horie, K., Saita, Y., Iida, E., Honda, K., & Tsujimoto, G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15263.x · Cited by 29
VACM-1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule
Burnatowska-Hledin, M. A., Lazdins, I. B., Listenberger, L. L., Zhao, P., Sharangpani, A., Folta, V., & Card, B. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.2.f199 · Cited by 29
Tsukaguchi, H., Matsubara, H., & Inada, M. (1995) · Kidney International · doi:10.1038/ki.1995.327 · Cited by 29
Wiśniewski, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9504-2_11 · Cited by 31
Urinary concentration: different ways to open and close the tap
Böckenhauer, D., & Bichet, D. G. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2526-4 · Cited by 28
Shapiro, J., & Richardson, G. E. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00126-e · Cited by 27
Friedman, E., Bale, A. E., Carson, E., Boson, W. L., Nordenskjöld, M., Ritzen, M. E., Ferreira, P. C., Jammal, A., & Marco, L. A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8457 · Cited by 27
Machida, K., Wakamatsu, S., Izumi, Y., Josifovska, T., Matsuzaki, T., Nakayama, Y., Kohda, Y., Inoue, T., Saito, H., Tomita, K., et al. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00154.2006 · Cited by 26
“The sequence of sense and antisense V2 receptor primers were defined by bases 349–368 (5 -TACCTGCAGATGGTGGGCAT-3 ) and bases 910–929 (5 -AGCAACACAAAGGGGGGTCT-3 ), respectively (9, 20).”
BackgroundAttenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor
Itoh, S., Yamada, S., Mori, T., Miwa, T., Tottori, K., Uwahodo, Y., Yamamura, Y., Fukuda, M., Yamamoto, K., Tanoue, A., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00005.2006 · Cited by 33
“been cloned (11, 12, 13) and belong to the family of seven”
Mishima, K., Tsukikawa, H., Inada, K., Fujii, M., Iwasaki, K., Matsumoto, Y., Abe, K., Egawa, T., & Fujiwara, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01200-6 · Cited by 26
Yuasa, H., Ito, M. A., Oiso, Y., Kurokawa, M., Watanabe, T., Oda, Y., Ishizuka, T., Tani, N., Ito, S., & Shibata, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.361 · Cited by 26
Sun, S., Cao, H. W., Yao, N., Zhao, L., Zhu, X.-F., Ni, E., Zhu, Q., & Zhu, W. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0292-y · Cited by 29
Role of vasopressin in rat distal colon function
Cristià, E., Amat, C., Naftalin, R. J., & Moretó, M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.118315 · Cited by 25
“AVP acts by two different G-protein-coupled receptor subtypes, V1 and V2 (Morel et al. 1992; Lolait et al. 1992).”
BackgroundLee, S., Choi, I. Y., Kang, S. S., & RIVIER, C. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.015 · Cited by 28
GRK2/β‐arrestin mediates arginine vasopressin‐induced cardiac fibroblast proliferation
Chen, Y., Xu, F., Zhang, L., Wang, X., Wang, Y., Woo, A. Y., & Zhu, W. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12696 · Cited by 26
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463
Gal, C. S., Raufaste, D., Double-Cazanave, E., Guillon, G., Garcia, C., Pascal, M., & Maffrand, J. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00322.x · Cited by 25
Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease
Mancinelli, R., Franchitto, A., Glaser, S. S., Vetuschi, A., Venter, J. K., Sferra, R., Pannarale, L., Olivero, F., Carpino, G., Alpini, G. D., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.93 · Cited by 27
Vasopressin receptor subtypes and renal sodium transport
Natochin, Y. V., & Golosova, D. (2020) · Vitamins and hormones · doi:10.1016/bs.vh.2019.08.013 · Cited by 24
Immunolocalization of V1 vasopressin receptors in the rat kidney using anti-receptor antibodies
González, C. B., Figueroa, C. D., Reyes, C. E., Caorsi, C. E., Troncoso, S., & Menzel, D. (1997) · Kidney International · doi:10.1038/ki.1997.445 · Cited by 24
Receptor‐Specific Antagonists of Vasopressin and Oxytocin
Manning, M., STOEV, S., Chan, W. Y., & Sawyer, W. H. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55550.x · Cited by 24
Mutations in the vasopressin V2 receptor gene in two families with nephrogenic diabetes insipidus.
Holtzman, E. J., Kolakowski, L. F., Geifman-Holtzman, O., O'brien, D., Rasoulpour, M., Guillot, A. P., & Ausiello, D. A. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v52169 · Cited by 24
Water channels in the kidney collecting duct
Sasaki, S., Fushimi, K., Ishibashi, K., & Marumo, F. (1995) · Kidney International · doi:10.1038/ki.1995.391 · Cited by 24
An Update on Pharmacologic Management of Neonatal Hypotension: When, Why, and Which Medication
Agakidou, E., Chatziioannidis, I., Kontou, A., Stathopoulou, T., Chotas, W., & Sarafidis, K. (2024) · Children · doi:10.3390/children11040490 · Cited by 27
“Furthermore, stimulation of V2 receptors in the kidney increases reabsorption of free water [154,156].”
BackgroundVasopressin and oxytocin receptor mRNA expression during rat telencephalon development
Chen, Q., Schreiber, S. S., & Brinton, R. D. (2000) · Neuropeptides · doi:10.1054/npep.2000.0809 · Cited by 25
“5′GGC ACC AGA CTG GCG TGT AT3′ (nt 735–754) (reverse) for V2 receptor cDNA fragment (Lolait et al., 1992) (3) 5′ACA TCA CCT TCC GCT TCT AT3′ (nt 3482–3501); (forward) and 5′TTG AAG CTG ATG AGG CCG TA3′ (nt”
BackgroundXu, F., Sun, S., Wang, X., Ni, E., Zhao, L., & Zhu, W. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.107698 · Cited by 23
“To date, three vasopressin receptor subtypes (V1AR, V2R, and V1BR, also termed V3R) have been found in humans (Lolait et al., 1992; Morel et al., 1992; de Keyzer et al., 1994).”
BackgroundLiu, M., Sun, Y., Xu, M., Yu, X., Zhang, Y., Huang, S., Ding, G., Zhang, A., & Jia, Z. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00234.2017 · Cited by 23
“AVP binds to the type 2 vasopressin receptor (V2R) to modulate AQP2 activity to promote water reabsorption in the collecting ducts (22).”
BackgroundJung, H. J., & Kwon, T. (2019) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.19.002 · Cited by 24
“In 1992, Lolait et al [21] cloned AVPR2 and subsequently, several studies identified that mutations in the AVPR2 gene on the X-chromosome are associated with X-linked nephrogenic diabetes insipidus (NDI) in humans [21- 24].”
BackgroundInfluentialA molecular approach to inherited kidney disorders
Knebelmann, B., Antignac, C., Gübler, M.-C., & Grünfeld, J. (1993) · Kidney International · doi:10.1038/ki.1993.370 · Cited by 23
Cellular Actions of Arginine Vasopressin in the Kidney.
Ishikawa, S. (1993) · Endocrine Journal · doi:10.1507/endocrj.40.373 · Cited by 23
From vasopressin receptor to water channel: intracellular traffic, constraint and by-pass
Laycock, J. F., & Hanoune, J. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590361 · Cited by 23
“The V2 receptor, cloned in the rat (Lolait et al. 1992) and in the human (Birnbaumer et al. 1992a), is a member of a family of proteins having seven intramembranous segments and three extracellular and four intracellular domains.”
BackgroundProperties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors
Ala, Y., Morin, D., Mahé, E., de la Cotte, N., Mouillac, B., Jard, S., Barberis, C., Tribollet, E., Dreifuss, J.-J., Sawyer, W. H., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01021-2 · Cited by 23
Transcriptional Regulation of the Pituitary Vasopressin V1b Receptor Involves a GAGA-binding Protein
Volpi, S., Rabadan-Diehl, C., Cawley, N., & Aguilera, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201508200 · Cited by 23
Kimura, T., & Ivell, R. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-49421-8_7 · Cited by 22
Hasunuma, I., Toyoda, F., Kadono, Y., Yamamoto, K., Namiki, H., & Kikuyama, S. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1079-0 · Cited by 25
“In mammalian species, at least three subtypes of receptors for AVP, namely V1a, V2, and V1b, have been identified (Lolait et al. 1992; Morel et al. 1992; Sugimoto et al. 1994).”
BackgroundEffects of the renal medullary pH and ionic environment on vasopressin binding and signaling
Zalyapin, E. A., Bouley, R., Hasler, U., Vilardaga, J., Lin, H. Y.-F., Brown, D., & Ausiello, D. A. (2008) · Kidney International · doi:10.1038/ki.2008.412 · Cited by 22
“These include: (1) increasing AQP2 expression independently of VP,75–77 (2) increasing VP binding and signaling via the V2R in acidic conditions, (3) increasing the efficiency of the VP/V2R association by reducing affinity of the V2R for oxytocin and reducing the affinity of the V1R for VP, and (4) increasing cAMP gen…”
BackgroundDürr, J. A., Hensen, J., Ehnis, T., Blankenship, M. S., & Klein), (. T. T. A. O. C. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f799 · Cited by 22
“Second, CP also requires intact ADH receptors because it has no effect in X-linked nephrogenic DI (1), ADHresistant polyuric states that result from mutations in the renal ADH isoreceptor gene (7, 44).”
BackgroundHeterotrimeric G protein signaling in polycystic kidney disease
Hama, T., & Park, F. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00027.2016 · Cited by 23
“Previous studies focusing on urine-concentrating mechanisms have observed that there is a cooperative effect on cAMP production between ANG II and AVP on their respective AT1R and V2R, respectively (89, 157).”
BackgroundInfluentialV2 vasopressin receptor mutations
Makita, N., Manaka, K., Sato, J., & Iiri, T. (2020) · Vitamins and hormones · doi:10.1016/bs.vh.2019.08.012 · Cited by 22
A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptors
Lemaire, W., O’Brien, J. A., Burno, M., Chaudhary, A., Dean, D. C., Williams, P. D., Freidinger, R. M., Pettibone, D. J., & Williams, D. L. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02048-4 · Cited by 23
Expression of mRNAs Encoding Hormone Receptors in the Endolymphatic Sac of the Rat
Furuta, C. S. H. (1999) · Acta Oto-Laryngologica · doi:10.1080/00016489950181936 · Cited by 22
Sarmiento, J., Ehrenfeld, P., Añazco, C. C., Reyes, C. E., Troncoso, S., Figueroa, C. D., Meller-esterl, W., & Gonzelez, C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00426.x · Cited by 22
“5 kD and a single potential N-glycosylation site for V 2”
BackgroundNeuropeptide Receptors and Astrocytes
Krisch, B., & Mentlein, R. (1994) · International review of cytology · doi:10.1016/s0074-7696(08)62407-9 · Cited by 22
Nephrogenic diabetes insipidus: identification of the genetic defect
Knoers, N. V. A. M., van den Ouweland, A., Dreesen, J. C. F. M., Verdijk, M. A. J., Monnens, L. A. H., & van Oost, B. A. (1993) · Pediatric Nephrology · doi:10.1007/bf00852579 · Cited by 22
“[19] that of its counterpart in the rat.”
BackgroundAquaporin-2 Water Channels and Vasopressin Antagonists in Edematous Disorders
Schrier, R. W., Ohara, M., Rogachev, B. V., Xu, L., & Knotek, M. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2765 · Cited by 21
Yamamoto, K., Ikeda, U., Okada, K., Saito, T., & Shimada, K. (1997) · Hypertension Research · doi:10.1291/hypres.20.209 · Cited by 22
Models of human endocrine disorders in transgenic rodents
Stewart, T. A. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90038-g · Cited by 21
Gene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 24
“Each discrete region plays a different physiological role through the three different vasopressin receptors, such as V1a (Morel et al. 1992), V1b (Sugimoto et al. 1994), and V2 (Lolait et al. 1992) receptor.”
Disorders of the Posterior Pituitary
Srivatsa, A., & Majzoub, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00012-9 · Cited by 23
Renal and Central Vasopressin Receptors: Immunocytochemical Localization
Fahrenholz, F., Jurzak, M., Gerstberger, R., & Haase, W. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55548.x · Cited by 20
The Cell Biology of Vasopressin Action
Brown, D., & Fenton, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10011-9 · Cited by 21
Rawat, A., Chaube, R., & Joy, K. P. (2018) · Fish Physiology and Biochemistry · doi:10.1007/s10695-018-0590-1 · Cited by 21
Characterization of the human type II Na/P i -cotransporter promoter
Hilfiker, H., Kvietikova, I., Hartmann, C., Stange, G., & Murer, H. (1998) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050676 · Cited by 19
“The promoter regions for several proteins preferentially expressed in the kidney have been characterized, including those for aquaporin-2 (AP2) [25], the V 2 vasopressin receptor [ 14 , 16], the parathyroid hormone (PTH)/PTH-related peptide receptor [1, 3], the Na/K/Cl-cotransporter [12], the renin [6] and the γ-gluta…”
BackgroundExpression of mRNA encoding vasopressin V1a, vasopressin V2, and ANP-B receptors in the rat cochlea
Furuta, H., Luo, L., Ryan, A. F., & Mori, N. (1998) · Hearing Research · doi:10.1016/s0378-5955(98)00009-4 · Cited by 18
Nakayama, Y., Takano, Y., Eguchi, K., Migita, K., Saito, R., Tsujimoto, G., & Kamiya, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00274-7 · Cited by 20
Development of Function in the Metanephric Kidney
Satlin, L. M., Woda, C. B., & Schwartz, G. J. (2003) · Elsevier eBooks · doi:10.1016/b978-012722441-1/50020-8 · Cited by 19
Metadata
- Authors
- Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J.
- Affiliations
- National Institute of Mental Health (US)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1992-05
- Volume
- 357
- Issue
- 6376
- Pages
- 336-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2131706912
- Cited by
- 524
- References
- 27
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 15 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 10 · 2013: 16 · 2012: 8
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- V2 receptor, vasopressin, nephrogenic diabetes insipidus, G protein-coupled receptors, adenylate cyclase, antidiuretic effect, kidney, receptor cloning, cDNA expression, X chromosome, X-linked recessive disorder, receptor mRNA expression
- MeSH terms
- Adenylyl Cyclases, Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Cloning, Molecular, Diabetes Insipidus, DNA, Humans, Kidney, Genetic Linkage, Molecular Sequence Data, Receptors, Angiotensin, Translocation, Genetic, X Chromosome, Restriction Mapping, Gene Expression, Polymerase Chain Reaction, Receptors, Vasopressin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.